102 related articles for article (PubMed ID: 21789168)
1. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.
Mancini R; Giarnieri E; De Vitis C; Malanga D; Roscilli G; Noto A; Marra E; Laudanna C; Zoppoli P; De Luca P; Affuso A; Ruco L; Di Napoli A; Mesiti G; Aurisicchio L; Ricci A; Mariotta S; Pisani L; Andreetti C; Viglietto G; Rendina EA; Giovagnoli MR; Ciliberto G
PLoS One; 2011; 6(7):e21320. PubMed ID: 21789168
[TBL] [Abstract][Full Text] [Related]
2. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.
Ricci A; De Vitis C; Noto A; Fattore L; Mariotta S; Cherubini E; Roscilli G; Liguori G; Scognamiglio G; Rocco G; Botti G; Giarnieri E; Giovagnoli MR; De Toma G; Ciliberto G; Mancini R
Cell Cycle; 2013 Jun; 12(11):1696-703. PubMed ID: 23656788
[TBL] [Abstract][Full Text] [Related]
3. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma.
Laberiano-Fernandez C; Gan Q; Wang SM; Tamegnon A; Wistuba I; Yoon E; Roy-Chowdhuri S; Parra ER
J Am Soc Cytopathol; 2024; 13(3):161-173. PubMed ID: 38519275
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of cancer stem cell-related marker expression is associated with three-dimensional structures in malignant pleural effusion produced by lung adenocarcinoma.
Lin YY; Lin YS; Liang CW
Cytopathology; 2024 Jan; 35(1):105-112. PubMed ID: 37897199
[TBL] [Abstract][Full Text] [Related]
5. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
[TBL] [Abstract][Full Text] [Related]
6. Non-small-cell lung cancers: a heterogeneous set of diseases.
Chen Z; Fillmore CM; Hammerman PS; Kim CF; Wong KK
Nat Rev Cancer; 2014 Aug; 14(8):535-46. PubMed ID: 25056707
[TBL] [Abstract][Full Text] [Related]
7. Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells.
Ascenzi F; Esposito A; Bruschini S; Salvati V; De Vitis C; De Arcangelis V; Ricci G; Catizione A; di Martino S; Buglioni S; Bassi M; Venuta F; De Nicola F; Massacci A; Grassucci I; Pallocca M; Ricci A; Fanciulli M; Ciliberto G; Mancini R
Cell Death Dis; 2024 Apr; 15(4):303. PubMed ID: 38684666
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.
Ozmen ZC; Kupeli M
Biochem Med (Zagreb); 2023 Oct; 33(3):030701. PubMed ID: 37841777
[TBL] [Abstract][Full Text] [Related]
9. An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention.
Peter RM; Chou PJ; Shannar A; Patel K; Pan Y; Dave PD; Xu J; Sarwar MS; Kong AT
Pharm Res; 2023 Nov; 40(11):2699-2714. PubMed ID: 37726406
[TBL] [Abstract][Full Text] [Related]
10. Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing.
Laure A; Rigutto A; Kirschner MB; Opitz L; Grob L; Opitz I; Felley-Bosco E; Hiltbrunner S; Curioni-Fontecedro A
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345150
[TBL] [Abstract][Full Text] [Related]
11. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications.
Zeng X; Ma Q; Li XK; You LT; Li J; Fu X; You FM; Ren YF
Front Bioeng Biotechnol; 2023; 11():1205157. PubMed ID: 37304140
[TBL] [Abstract][Full Text] [Related]
12. Establishment and Characterization of Patient-Derived Xenograft Model of Non-Small-Cell Lung Cancer Derived from Malignant Pleural Effusions.
Liao H; Zhou S; Chen S; Li J; Zhang Z; Meng L; Liu Q; Wu Y; He Y; Li M
Cancer Manag Res; 2023; 15():165-174. PubMed ID: 36824151
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.
Zhou Y; Zhan Y; Jiang W; Liu H; Wei S
Oxid Med Cell Longev; 2022; 2022():4802338. PubMed ID: 35757505
[TBL] [Abstract][Full Text] [Related]
14. Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
Bruschini S; Pallocca M; Sperandio E; D'Ambrosio L; Ascenzi F; De Vitis C; Salvati V; Esposito A; Di Martino S; De Nicola F; Paolini F; Fattore L; Alessandrini G; Facciolo F; Foddai ML; Bassi M; Venuta F; D'Ascanio M; Ricci A; D' Andrilli A; Napoli C; Aurisicchio L; Fanciulli M; Rendina EA; Ciliberto G; Mancini R
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35584864
[TBL] [Abstract][Full Text] [Related]
15. Role of circulating tumor cell spheroids in drug resistance.
Hamilton G; Rath B
Cancer Drug Resist; 2019; 2(3):762-772. PubMed ID: 35582592
[TBL] [Abstract][Full Text] [Related]
16. The Fight against Cancer by Microgravity: The Multicellular Spheroid as a Metastasis Model.
Grimm D; Schulz H; Krüger M; Cortés-Sánchez JL; Egli M; Kraus A; Sahana J; Corydon TJ; Hemmersbach R; Wise PM; Infanger M; Wehland M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328492
[TBL] [Abstract][Full Text] [Related]
17. BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell Carcinomas.
Fisher ML; Balinth S; Hwangbo Y; Wu C; Ballon C; Wilkinson JE; Goldberg GL; Mills AA
Cancer Res; 2021 Dec; 81(24):6246-6258. PubMed ID: 34697072
[TBL] [Abstract][Full Text] [Related]
18. ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion.
Kanayama T; Taniguchi T; Tomita H; Niwa A; Noguchi K; Matsuo M; Imaizumi Y; Kuroda T; Hatano Y; Okazaki I; Kato T; Hara A
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441397
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
Fattore L; Mancini R; Ciliberto G
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202944
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
